UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 864

Sortiert nach

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Journal of clinical oncology, 2024-03, p.JCO2301500-JCO2301500

2024

Link zum Volltext

Verfügbarkeit prüfen

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2490-2498

2017

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

Journal of clinical oncology, 2020-02, Vol.38 (6), p.538-547

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of niraparib in patients with advanced melanoma with genetic homologous recombination (HR) mutation/alteration

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9596-TPS9596

Kim, Kevin B.

2023

Link zum Volltext

Verfügbarkeit prüfen

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.661-668

2016

Link zum Volltext

Verfügbarkeit prüfen

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Journal of clinical oncology, 2022-08, Vol.40 (23), p.2546-2556

2022

Link zum Volltext

Verfügbarkeit prüfen

Desire for Information and Involvement in Treatment Decisions: Elderly Cancer Patients' Preferences and Their Physicians' Perceptions

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5275-5280

2007

Link zum Volltext

Verfügbarkeit prüfen

Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4465-4470

2013

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7703-7720

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3205-3211

2013

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1213-1227

2023

Link zum Volltext

Verfügbarkeit prüfen

Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment

Journal of clinical oncology, 2022-03, Vol.40 (8), p.876-883

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Journal of clinical oncology, 2013-02, Vol.31 (4), p.482-489

2013

Link zum Volltext

Verfügbarkeit prüfen

Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model

Journal of clinical oncology, 2022-06, Vol.40 (16), p.1732-1740

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Journal of clinical oncology, 2009-12, Vol.27 (34), p.5794-5799

2009

Link zum Volltext

Verfügbarkeit prüfen

Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

Journal of clinical oncology, 2019-07, Vol.37 (19), p.1638-1646

2019

Link zum Volltext

Verfügbarkeit prüfen

Two-photon probes for pH: Detection of human colon cancer using two-photon microscopy

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.607-607

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1580-1590

2020

Link zum Volltext

Verfügbarkeit prüfen

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

Journal of clinical oncology, 2021-07, Vol.39 (20), p.JCO2003488-2303

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3133-3140

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1 , BRCA2 , or PALB2

Journal of clinical oncology, 2021-08, Vol.39 (22), p.2497-2505

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2499-2506

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 864

Suche als RSS-Feed

Aktive Filter

SpracheCroatian

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(864)
Mit Volltextzugriff
(864)

Publikationsform

Artikel
(864)

Sprache

Englisch
(864)
Japanisch
(45)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(138)
Oncology
(138)
Life Sciences & Biomedicine
(131)
Science & Technology
(131)
Female
(112)
Male
(110)
Middle Aged
(86)
Adult
(82)
Aged
(77)
Biological And Medical Sciences
(75)
Medical Sciences
(75)
Original Reports
(47)
Tumors
(45)
Cancer Research
(44)
Aged, 80 And Over
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Treatment Outcome
(34)
Neoplasm Staging
(33)
Adolescent
(29)
Child
(26)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J. Clin. Oncol
(1)

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

Phase II study of niraparib in patients with advanced melanoma with genetic homologous recombination (HR) mutation/alteration

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Desire for Information and Involvement in Treatment Decisions: Elderly Cancer Patients' Preferences and Their Physicians' Perceptions

Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

Two-photon probes for pH: Detection of human colon cancer using two-photon microscopy

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer

Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1 , BRCA2 , or PALB2

Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study

Aktive Filter

Suchergebnisse filtern